Clinical trial
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing…
NCT00096590 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00096590 |
|---|---|
| Title | Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery |
| Official title | Evaluation of a Novel Blood Test Hypercoagulability in Surgical Patients With Metastatic Carcinoma: A Pilot Study |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Thromboembolism, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Other, Procedure |
| Interventions | coagulation study, immunoenzyme technique, laboratory biomarker analysis, physiologic testing, study of high risk factors |
| Enrollment | 60 |
| Start date | Nov 1, 2004 |
| First posted | Nov 12, 2004 |
| Last update posted | May 12, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: